Why the study?
Does the combination of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predict in-hospital and long-term mortality in patients with STEMI undergoing primary PCI?
Population
2,518 patients with ST-Segment Elevation Myocardial Infarction undergoing primary percutaneous coronary…
Comparison
High risk or intermediate risk vs Low risk (neither PLR nor NLR above threshold)
Design
Cohort
Follow-up
in-hospital and long-term
Authors
Loading...
May refine STEMI risk stratification post-PCI; extends biomarker data but leaves open prospective validation and practice change.
Does the combination of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predict in-hospital and long-term mortality in patients with STEMI undergoing primary PCI?
The combination of elevated neutrophil-lymphocyte ratio and platelet-lymphocyte ratio independently predicts higher in-hospital and long-term mortality in STEMI patients undergoing primary PCI.
Çiçek et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: